|1.||Mukhtar, Hasan: 19 articles (11/2014 - 02/2002)|
|2.||Hara, Yukihiko: 12 articles (10/2010 - 02/2002)|
|3.||Yang, Chung S: 10 articles (01/2014 - 09/2002)|
|4.||Suganuma, Masami: 9 articles (03/2015 - 06/2002)|
|5.||Dou, Q Ping: 9 articles (05/2012 - 10/2002)|
|6.||Ahmad, Nihal: 9 articles (01/2010 - 02/2002)|
|7.||Fujiki, Hirota: 8 articles (03/2015 - 06/2002)|
|8.||Adhami, Vaqar M: 8 articles (11/2014 - 02/2002)|
|9.||Hsu, Stephen: 7 articles (12/2015 - 07/2003)|
|10.||Siddiqui, Imtiaz A: 7 articles (11/2014 - 04/2006)|
07/01/2015 - "DIM-D-N pretreatment prior to UVB exposure delayed tumor initiation and reduced tumor multiplicity (p < 0.05) at the end of the study compared to Epigallocatechin gallate (EGCG) gel pretreatment. "
04/01/2015 - "Epigallocatechin-3-gallate (EGCG) inhibits cancer progression by attenuating NF-κB p65 activity, which is upregulated in CSCs and plays an important role in epithelial-mesenchymal transition (EMT). "
03/01/2014 - "Epigallocatechin-3-gallate (EGCG) has been shown to inhibit the growth and induce apoptosis of certain cancer cells. "
10/01/2013 - "Epigallocatechin-3-gallate (EGCG) has been shown to inhibit the metastatic activity of certain cancer cells. "
01/04/2013 - "Conversely, demethylation of these promoters has been ascribed to the natural anti-cancer drug, epigallocatechin-3-gallate (EGCG). "
|2.||Breast Neoplasms (Breast Cancer)
10/01/2014 - "Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels."
05/01/2013 - "In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells."
01/01/2013 - "Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells."
06/01/2008 - "Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75."
01/01/2013 - "Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization."
12/01/2012 - "Epigallocatechin-3-gallate (EGCG) has antiangiogenic, antioxidant, and antifibrotic properties that may have therapeutic potential for the treatment of cirrhosis induced by hepatitis C virus (HCV). "
06/29/2010 - "The anti-inflammatory and antioxidant effects of epigallocatechin-3-gallate (EGCG) are considered important forces in attenuate liver injury and fibrosis. "
08/01/2014 - "Is epigallocatechin-3-gallate (EGCG) treatment effective in the treatment of fibrosis in endometriosis? "
02/01/2009 - "This study was carried out in order to investigate the effects of epigallocatechin gallate (EGCG) on myocardial fibrosis and cell proliferation in cardiac hypertrophy. "
04/01/2015 - "Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice."
01/01/2013 - "Therapeutic efficacy of epigallocatechin gallate-loaded nanoliposomes against burn wound infection by methicillin-resistant Staphylococcus aureus."
05/01/2015 - "The Protective Effects of Epigallocatechin Gallate Against Distant Organ Damage After Severe Skin Burns--Experimental Study Using a Rat Model of Thermal Trauma."
01/01/2015 - "To evaluate the efficacy of epigallocatechin gallate (EGCG) in treatment of corneal alkali burn injury in mice. "
01/01/2015 - "[Efficacy of epigallocatechin gallate in treatment of alkali burn injury of murine cornea]."
|5.||Prostatic Neoplasms (Prostate Cancer)
08/01/2011 - "To assess the influence of epigallocatechin-3-gallate (EGCG) on the efficacy of ionizing radiation on prostate cancer cells because of the increased use of dietary interventions, especially by patients with prostate cancer. "
07/01/2013 - "Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells."
08/01/2010 - "The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells."
12/01/2008 - "[Growth inhibition of prostate cancer cells by epigallocatechin-3-gallate in the presence of Zn2+ in vitro]."
01/10/2008 - "Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation."
|2.||Catechin (Z 7300)
|7.||Polyethylene Glycols (Polyethylene Glycol)
|8.||poly(lactic acid) (polylactic acid)
|1.||Drug Therapy (Chemotherapy)
|3.||Heterologous Transplantation (Xenotransplantation)